A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response
Medical Science Monitor · 2025
DOI: 10.12659/msm.949300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Dinah V Parums. Beteiligte Einrichtung: Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.
Zitieren
APA
Parums, D. V. (2025). A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response. Medical Science Monitor. https://doi.org/10.12659/msm.949300
Vancouver
Parums DV. A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response. Medical Science Monitor. 2025. doi:10.12659/msm.949300
BibTeX
@article{Parums2025,
author = {Parums, Dinah V},
title = {A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.949300}
}
EUVIMED